A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma
NCT01970358
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Melanoma
Interventions
BIOLOGICAL:
Poly-ICLC
BIOLOGICAL:
Peptides
Sponsor
Patrick Ott, MD, PhD